Delivery Order SPE2DB22D2007-SPE2DB24FJ3VW
Award Date
7/1/24
Potential Completion Date
7/2/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,651.87 firm fixed-price delivery order is for the provision of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various medical applications. The contract has an ultimate completion date of March 11, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,727.55, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, and has an ultimate completion date of February 27, 2025. The contract is a Delivery Order under a Firm Fixed Price type. This award is not designated with a set-aside and appears to be part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,300.52 delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML syringes. The contract has an ultimate completion date of October 24, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,195.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract has an ultimate completion date of November 4, 2022 and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order federal contract award valued at $24,268.97, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a performance period ending on July 24, 2024. The award is not associated with a set-aside program and represents an open competition. AmerisourceBergen holds a significant Indefinite...
This is a $6,615.03 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a period of performance through February 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for $7,518.77. The contract is for the medical product EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, with a completion date of November 15, 2024. The contract is a firm fixed price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,671.35, is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in healthcare. This contract is not designated as a set-aside. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $14,252.64, is for the delivery of EUFLEXXA 20 MG/2 ML syringes to support military treatment programs and facilities. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,072.14 and is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product. The contract has a period of performance that runs through February 25, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition....